MedTrace Logo

Fish Protein Supplementation and Sarcopenia Outcomes in Carehomes

NCT05637450 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2022-12-05

No results posted yet for this study

Summary

The proposed study aims to investigate the effect of consuming 12.5g (twice daily) Blue Whiting Protein Hydrolysates (BWPH) daily for 6 weeks on whole body lean mass tissue and measures of muscle strength and functionality in older adults residing in residential care facilities.

Conditions

Interventions

DIETARY_SUPPLEMENT

Blue Whiting Protein Hydrolysate

25g Blue Whiting Protein Hydrolysates mixed with an everyday food / drink product daily for 6 weeks

DIETARY_SUPPLEMENT

Placebo

Isocalorific maltodextrin citrus flavoured powder mixed with an everyday food / drink product for 6 weeks

Sponsors & Collaborators

  • University of Limerick

    collaborator OTHER

  • Bio-Marine Ingredients Ireland

    collaborator UNKNOWN

  • University of Ulster

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2023-08-31
Completion
2023-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05637450 on ClinicalTrials.gov